Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
The Lancet. Oncology
|
February 19, 2013
Induction chemotherapy challenges for head and neck cancer
Sandrine Faivre, Sébastien Albert, Eric Raymond
Current Oncology Reports
|
November 16, 2019
Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
Eliane Tang, Lucien Lahmi, Nicolas Meillan, et al.
Annales De Pathologie
|
October 2, 2017
[A rare endolaryngeal tumor]
Carine Ngo, Sébastien Albert, Beatrix Barry, et al.
Expert Opinion on Investigational Drugs
|
June 24, 2010
New inhibitors of the mammalian target of rapamycin signaling pathway for cancer
Sébastien Albert, Maria Serova, Chantal Dreyer, et al.
The Laryngoscope
|
February 5, 2003
Total glossectomy without laryngectomy as first-line or salvage therapy
Béatrix Barry, Bertrand Baujat, Sébastien Albert, et al.
Targeted Oncology
|
May 3, 2011
Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors
Catherine Delbaldo, Sébastien Albert, Chantal Dreyer, et al.
AIDS (London, England)
|
January 26, 2016
Human papilloma virus prevalence in HIV patients with head and neck squamous cell carcinoma
Annabelle Picard, Cécile Badoual, Muriel Hourseau, et al.
Cancer Treatment Reviews
|
August 20, 2013
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
Head & Neck
|
March 8, 2013
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma
Sébastien Albert, Maria Eugenia Riveiro, Caroline Halimi, et al.
Oral Oncology
|
January 9, 2019
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy
Diane Evrard, Petr Szturz, Annemilaï Tijeras-Raballand, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
The Lancet. Oncology
|
February 19, 2013
Induction chemotherapy challenges for head and neck cancer
Sandrine Faivre, Sébastien Albert, Eric Raymond
Current Oncology Reports
|
November 16, 2019
Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
Eliane Tang, Lucien Lahmi, Nicolas Meillan, et al.
Annales De Pathologie
|
October 2, 2017
[A rare endolaryngeal tumor]
Carine Ngo, Sébastien Albert, Beatrix Barry, et al.
Expert Opinion on Investigational Drugs
|
June 24, 2010
New inhibitors of the mammalian target of rapamycin signaling pathway for cancer
Sébastien Albert, Maria Serova, Chantal Dreyer, et al.
The Laryngoscope
|
February 5, 2003
Total glossectomy without laryngectomy as first-line or salvage therapy
Béatrix Barry, Bertrand Baujat, Sébastien Albert, et al.
Targeted Oncology
|
May 3, 2011
Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors
Catherine Delbaldo, Sébastien Albert, Chantal Dreyer, et al.
AIDS (London, England)
|
January 26, 2016
Human papilloma virus prevalence in HIV patients with head and neck squamous cell carcinoma
Annabelle Picard, Cécile Badoual, Muriel Hourseau, et al.
Cancer Treatment Reviews
|
August 20, 2013
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
Head & Neck
|
March 8, 2013
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma
Sébastien Albert, Maria Eugenia Riveiro, Caroline Halimi, et al.
Oral Oncology
|
January 9, 2019
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy
Diane Evrard, Petr Szturz, Annemilaï Tijeras-Raballand, et al.
Page
of 2